Therefore, developing a more profound understanding of the role of CD8+ cytotoxic lymphocytes in the molecular mechanisms that govern BBB integrity during CM disease is likely to be crucial for the development of promising therapeutic solutions. Here, CD8A is linked to cutaneous mastocytosis.